Imiquimod

Imiquimod

SCHEMBL9602249

CC(C)Cn1cnc2c(N)nc3ccccc3c21.CS(=O)(=O)O.O

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TLR7

The experimentally established mechanism targets of Imiquimod. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TLR7 known ✓ Q9NYK1 14/20 0.82
PDE4D Q08499 2/20 0.82
LMNA P02545 1/20 0.82
POLB P06746 1/20 0.82
HRH2 P25021 1/20 0.82
ADRA1D P25100 1/20 0.82
HTR2A P28223 1/20 0.82
ADORA2A P29274 1/20 0.82
ADRA1A P35348 1/20 0.82
NUDT1 P36639 1/20 0.82
HTR2B P41595 1/20 0.82
KCNH2 Q12809 1/20 0.82
TLR8 Q9NR97 3/20 0.47
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
MAPK14 Q16539 3/20 0.40
TEK Q02763 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Imiquimod SCHEMBL570774 0.91 TLR7 (1.00) TLR7PDE4DLMNAPOLBHRH2
Imiquimod SCHEMBL26136 0.91 TLR7 (1.00) TLR7PDE4DLMNAPOLBHRH2
Imiquimod SCHEMBL29357252 0.91 TLR7 (1.00) TLR7PDE4DLMNAPOLBHRH2
Imiquimod SCHEMBL5262205 0.90 TLR7 (0.88) TLR7PDE4DLMNAPOLBHRH2
Imiquimod SCHEMBL29029396 0.90 TLR7 (0.93) TLR7PDE4DLMNAPOLBHRH2
Imiquimod SCHEMBL1301796 0.90 TLR7 (0.97) TLR7PDE4DLMNAPOLBHRH2
Imiquimod SCHEMBL17962753 0.90 TLR7 (0.97) TLR7PDE4DLMNAPOLBHRH2
Imiquimod SCHEMBL3191041 0.89 TLR7 (0.86) TLR7PDE4DLMNAPOLBHRH2
Imiquimod SCHEMBL3415170 0.88 TLR7 (0.84) TLR7PDE4DLMNAPOLBHRH2
Imiquimod SCHEMBL9602834 0.87 TLR7 (0.82) TLR7PDE4DLMNAPOLBHRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0310950-B1 Quinoline intermediates for the synthesis of 1H-imidazo[4,5-c]quinolines and 1H-imidazo[4,5-c]quinolin-4-amimes RIKER LABORATORIES, INC. (US) 1993-01-13 EP disclosed
EP-0145340-B1 1H-Imidazo[4,5-c]quinolines and 1H-imidazo[4,5-c]quinolin-4-amines RIKER LABORATORIES, INC. (US) 1990-01-24 EP disclosed
EP-0310950-A1 Quinoline intermediates for the synthesis of 1H-imidazo[4,5-c]quinolines and 1H-imidazo[4,5-c]quinolin-4-amimes RIKER LABORATORIES, INC. (US) 1989-04-12 EP disclosed
US-4689338-A 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use RIKER LABORATORIES, INC. (US) 1987-08-25 US disclosed
EP-0145340-A2 1H-Imidazo[4,5-c]quinolines and 1H-imidazo[4,5-c]quinolin-4-amines RIKER LABORATORIES, INC. (US) 1985-06-19 EP disclosed